It is also noteworthy that linc-ITGB1 and ROCK1 inhibitor treatment showed no significant effects on cells of normal liver tissue cell line THLE-3, thus linc-ITGB1 may be a safe therapeutic target for the treatment of HCC. Here, ROCK1 is linked to hepatocellular carcinoma.